Hacer Karataş

1.7k total citations
20 papers, 1.1k citations indexed

About

Hacer Karataş is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Hacer Karataş has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Organic Chemistry and 2 papers in Cell Biology. Recurrent topics in Hacer Karataş's work include Protein Degradation and Inhibitors (5 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related gene regulation (4 papers). Hacer Karataş is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related gene regulation (4 papers). Hacer Karataş collaborates with scholars based in United States, Türkiye and China. Hacer Karataş's co-authors include Shaomeng Wang, Yali Dou, Ming Lei, Elena A. Goun, Denzil Bernard, Laura Mezzanotte, Clemens W.G.M. Löwik, Liu Liu, Yong Chen and Elizabeth C. Townsend and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

Hacer Karataş

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hacer Karataş United States 14 911 131 110 103 101 20 1.1k
Rob Ruijtenbeek Netherlands 21 854 0.9× 215 1.6× 61 0.6× 219 2.1× 54 0.5× 64 1.2k
Magdalena M. Szewczyk Canada 22 1.3k 1.4× 70 0.5× 64 0.6× 106 1.0× 29 0.3× 39 1.6k
Amaury E. Fernández‐Montalván Germany 19 1.0k 1.1× 86 0.7× 137 1.2× 185 1.8× 40 0.4× 38 1.3k
Kevin R. Kupcho United States 10 481 0.5× 80 0.6× 81 0.7× 104 1.0× 51 0.5× 22 707
Sayumi Yamazoe United States 14 787 0.9× 85 0.6× 29 0.3× 118 1.1× 36 0.4× 31 967
Emily C. Dykhuizen United States 22 1.4k 1.5× 216 1.6× 59 0.5× 210 2.0× 46 0.5× 48 1.7k
Chengwei Zhang China 17 841 0.9× 40 0.3× 95 0.9× 167 1.6× 90 0.9× 46 1.3k
Henry E. Pelish United States 10 594 0.7× 128 1.0× 28 0.3× 130 1.3× 38 0.4× 22 913
G. Wayne Zhou United States 19 1.2k 1.3× 68 0.5× 38 0.3× 211 2.0× 59 0.6× 38 1.6k
Kotaro Sakamoto Japan 21 782 0.9× 56 0.4× 80 0.7× 367 3.6× 48 0.5× 56 1.2k

Countries citing papers authored by Hacer Karataş

Since Specialization
Citations

This map shows the geographic impact of Hacer Karataş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hacer Karataş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hacer Karataş more than expected).

Fields of papers citing papers by Hacer Karataş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hacer Karataş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hacer Karataş. The network helps show where Hacer Karataş may publish in the future.

Co-authorship network of co-authors of Hacer Karataş

This figure shows the co-authorship network connecting the top 25 collaborators of Hacer Karataş. A scholar is included among the top collaborators of Hacer Karataş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hacer Karataş. Hacer Karataş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ölgen, Süreyya, et al.. (2023). Synthesis and Anticancer Activity of Novel Indole Derivatives as DualEGFR/SRC Kinase Inhibitors. Current Medicinal Chemistry. 31(24). 3798–3817. 9 indexed citations
2.
Karataş, Hacer, et al.. (2022). An economical and practical procedure of favipiravir synthesis for the treatment of Covid-19. Chemical Papers. 77(3). 1695–1702. 3 indexed citations
3.
Karataş, Hacer, Mohammad Akbarzadeh, Hélène Adihou, et al.. (2020). Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket. Journal of Medicinal Chemistry. 63(20). 11972–11989. 43 indexed citations
4.
Pobbati, Ajaybabu V., Tom Mejuch, Sayan Chakraborty, et al.. (2019). Identification of Quinolinols as Activators of TEAD-Dependent Transcription. ACS Chemical Biology. 14(12). 2909–2921. 37 indexed citations
5.
Guo, Yijing, Ienglam Lei, Shuo Tian, et al.. (2019). Chemical suppression of specific C-C chemokine signaling pathways enhances cardiac reprogramming. Journal of Biological Chemistry. 294(23). 9134–9146. 22 indexed citations
6.
Karataş, Hacer, et al.. (2019). Real-Time Imaging and Quantification of Peptide Uptake in Vitro and in Vivo. ACS Chemical Biology. 14(10). 2197–2205. 8 indexed citations
7.
Mezzanotte, Laura, et al.. (2017). In Vivo Molecular Bioluminescence Imaging: New Tools and Applications. Trends in biotechnology. 35(7). 640–652. 211 indexed citations
8.
Karataş, Hacer, Yangbing Li, Liu Liu, et al.. (2017). Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)–Mixed Lineage Leukemia (MLL) Protein–Protein Interaction. Journal of Medicinal Chemistry. 60(12). 4818–4839. 75 indexed citations
9.
Zhang, Hui, Srimonta Gayen, Jie Xiong, et al.. (2016). MLL1 Inhibition Reprograms Epiblast Stem Cells to Naive Pluripotency. Cell stem cell. 18(4). 481–494. 49 indexed citations
10.
Xu, Jing, Li Li, Jie Xiong, et al.. (2016). MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program. Cell Discovery. 2(1). 16008–16008. 40 indexed citations
11.
Liu, Liu, Ienglam Lei, Hacer Karataş, et al.. (2016). Targeting Mll1 H3K4 methyltransferase activity to guide cardiac lineage specific reprogramming of fibroblasts. Cell Discovery. 2(1). 34 indexed citations
12.
Karataş, Hacer, Elizabeth C. Townsend, Fang Cao, et al.. (2015). Structure-based design of conformationally constrained cyclic peptidomimetics to target the MLL1-WDR5 protein–protein interaction as inhibitors of the MLL1 methyltransferase activity. Chinese Chemical Letters. 26(4). 455–458. 4 indexed citations
13.
Cao, Fang, Elizabeth C. Townsend, Hacer Karataş, et al.. (2014). Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage Leukemia. Molecular Cell. 53(2). 247–261. 232 indexed citations
14.
Karataş, Hacer, et al.. (2012). Synthesis and Potent In vitro Activity of Novel 1H‐Benzimidazoles as Anti‐MRSA Agents. Chemical Biology & Drug Design. 80(2). 237–244. 15 indexed citations
15.
Karataş, Hacer, Elizabeth C. Townsend, Fang Cao, et al.. (2012). High-Affinity, Small-Molecule Peptidomimetic Inhibitors of MLL1/WDR5 Protein–Protein Interaction. Journal of the American Chemical Society. 135(2). 669–682. 154 indexed citations
16.
Zhou, Haibin, Liu Liu, Jing Huang, et al.. (2012). Structure-Based Design of High-Affinity Macrocyclic Peptidomimetics to Block the Menin-Mixed Lineage Leukemia 1 (MLL1) Protein–Protein Interaction. Journal of Medicinal Chemistry. 56(3). 1113–1123. 75 indexed citations
17.
Karataş, Hacer, Elizabeth C. Townsend, Denzil Bernard, Yali Dou, & Shaomeng Wang. (2010). Analysis of the Binding of Mixed Lineage Leukemia 1 (MLL1) and Histone 3 Peptides to WD Repeat Domain 5 (WDR5) for the Design of Inhibitors of the MLL1−WDR5 Interaction. Journal of Medicinal Chemistry. 53(14). 5179–5185. 56 indexed citations
18.
19.
Özden, Seçkin, Hacer Karataş, Sulhiye Yıldız, & Hakan Göker. (2004). Synthesis and Potent Antimicrobial Activity of Some Novel 4‐(5, 6‐Dichloro‐1H‐benzimidazol‐2‐yl)‐N‐substituted Benzamides. Archiv der Pharmazie. 337(10). 556–562. 32 indexed citations
20.
Kazak, Canan, et al.. (2004). Methyl 1-n-butyl-2-(3,4-dichlorophenyl)-1H-benzimidazole-5-carboxylate. Acta Crystallographica Section E Structure Reports Online. 60(9). o1535–o1537. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rob Ruijtenbeek Breakdown of academic impact, for papers by Magdalena M. Szewczyk Breakdown of academic impact, for papers by Amaury E. Fernández‐Montalván Breakdown of academic impact, for papers by Kevin R. Kupcho Breakdown of academic impact, for papers by Sayumi Yamazoe Breakdown of academic impact, for papers by Emily C. Dykhuizen Breakdown of academic impact, for papers by Chengwei Zhang Breakdown of academic impact, for papers by Henry E. Pelish Breakdown of academic impact, for papers by G. Wayne Zhou Breakdown of academic impact, for papers by Kotaro Sakamoto
Rankless by CCL
2026